All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Unit of Diffusion Coefficient | NCIT_C68743 | [A unit of factor of proportionality representing the amount of substance diffusing across a unit area through a unit concentration gradient in unit time.] |
| MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells | NCIT_C107159 | [Irradiated allogeneic, HLA-A*0201 positive, plasmacytoid dendritic cells (pDCs) loaded with 4 melanoma peptides derived from the tumor associated antigens (TAAs) MelA/MART-1, gp100/pmel17, tyrosinase, and MAGE-A3, with potential immunostimulating and antineoplastic activities. Upon subcutaneous administration, the irradiated allogeneic pDCs may trigger functional multi-specific T cells from peripheral blood mononuclear cells and tumor-infiltrating lymphocytes, and activate the immune system to mount a cytotoxic T-lymphocyte response against HLA-A*0201 positive melanoma cancer cells expressing the TAAs MelA/MART-1, gp100/pmel17, tyrosinase, and MAGE-A3. These TAAs are upregulated in a variety of tumor cells. The pDCs are derived from a distinct subset of dendritic cells (DCs) with a plasma cell-like morphology and express a characteristic set of surface markers and may increase the anti-tumor immune responses.] |
| Biot | NCIT_C68907 | [A CGS unit of electric current equal to 10 ampere.] |
| Unit of Electric Current | NCIT_C67323 | |
| Ampere per Square Meter | NCIT_C68908 | [A SI derived unit of an electric current density which is equal to an electric current of one ampere circulating in a homogeneous conductor with a cross section area of one square meter.] |
| Unit of Electric Current Density | NCIT_C68745 | [A unit for measurement of magnitude of the electrical current per cross-sectional area.] |
| Volt per Meter | NCIT_C68909 | [A SI derived unit of electric field strength defined as the strength that exerts the force equal to one newton on an electric point charge of one coulomb.] |
| Unit of Electric Field Strength | NCIT_C68746 | [A unit of the force, exerted by electric field on an electric point charge.] |
| PSMA Peptide | NCIT_C29340 | [A peptide based on HLA-A*0201 restricted peptides of the prostate-specific membrane antigen (PSMA). Prostate epithelial cells express PSMA and overexpression has been detected in hormone refractory prostate carcinoma. Autologous dendritic cells are used to deliver the peptides to the patient. Recombinant PSMA peptide may trigger a cytotoxic T-cell response to prostate cancer cells.] |
| Vaccine Antigen | NCIT_C2835 | [A vaccine component consisting of a protein, small peptide, or polysaccharide, natural or synthetic, that once administered is bound by antibody, thereby inducing mechanisms of antibody-dependent cell-mediated cytotoxicity (ADCC). In cancer immunotherapy, a cancer vaccine containing specific tumor-associated antigens (TAAs) may be used to boost an immune response against a tumor expressing those TAAs. (NCI04)] |
| Talotrexin | NCIT_C29341 | [An antimetabolite analogue of aminopterin with potential antineoplastic activity. As a folate antagonist, talotrexin binds to and inhibits the function of dihydrofolate reductase, resulting in the inhibition of folate metabolism, DNA synthesis, and cell division. Hydrosoluble, talotrexin is actively transported into cells by the reduced folate carrier (RFC) and, therefore, is unlikely to be associated with P-glycoprotein-mediated multidrug resistance.] |
| Dihydrofolate Reductase | NCIT_C17191 | [Dihydrofolate reductase (187 aa, ~21 kDa) is encoded by the human DHFR gene. This protein is involved in folate metabolism and the synthesis of nucleotides and glycine.] |
| PTF | NCIT_C29342 | |
| Pyran Polymer | NCIT_C29343 | [A hydrocarbon-based polymer containing a pyran nucleus used to bioconjugate various drugs,. Use of a pyran polymer-drug bioconjugate may alter the biodistribution of a low molecular weight drug, resulting in disease-specific targeting with reduced drug access to sites of toxicity such as the bone marrow; the large size of the bioconjugate does not allow the active agent to pass the blood-bone marrow barrier. (NCI04)] |
| Imidazole-Pyrazole | NCIT_C29344 | [A synthetic agent, also known as IMPY, with antineoplastic properties. IMPY inhibits ribonucleotide reductase, an enzyme that converts ribonucleotides to deoxyribonucleotides during DNA synthesis; this agent specifically binds the smaller, nonheme-iron subunit of the enzyme. (NCI04)] |
| Left Ventricular Systolic Dysfunction, CTCAE 5.0 | NCIT_C146719 | [A disorder characterized by failure of the left ventricle to produce adequate output.] |
| Pancrelipase | NCIT_C29345 | [A standardized enzyme concentrate containing the pancreatic enzymes, lipase, protease and amylase used in enzyme substitution therapy. Lipase, protease and amylase break down fat, protein, and starches, respectively in the small intestine, thereby promoting digestion. Pancrelipase is used to reduce malabsorption when the pancreas is unable to secrete sufficient amounts of these enzymes.] |
| Pantoprazole | NCIT_C29346 | [A substituted benzimidazole and proton pump inhibitor with antacid activity. Pantoprazole is a lipophilic weak base that crosses the parietal cell membrane and enters the acidic parietal cell canaliculus where it becomes protonated, producing the active metabolite sulphenamide, which forms an irreversible covalent bond with two sites of the H+/K+-ATPase enzyme located on the gastric parietal cell, thereby inhibiting both basal and stimulated gastric acid production.] |
| Cytochrome P450 2C19 | NCIT_C25948 | [Cytochrome P450 2C19 (490 aa, ~56 kDa) is encoded by the human CYP2C19 gene. This protein is involved in steroid, terpenoid and drug metabolism.] |
| Million Colony Forming Units per Gram | NCIT_C68900 | [A derived unit of viable cell concentration defined as the number of million colony forming units (10E6 CFU) in one gram of substance.] |